WO1994001435B1 - New analgesic and nootropic drugs - Google Patents

New analgesic and nootropic drugs

Info

Publication number
WO1994001435B1
WO1994001435B1 PCT/EP1993/001743 EP9301743W WO9401435B1 WO 1994001435 B1 WO1994001435 B1 WO 1994001435B1 EP 9301743 W EP9301743 W EP 9301743W WO 9401435 B1 WO9401435 B1 WO 9401435B1
Authority
WO
WIPO (PCT)
Prior art keywords
general formula
naphtyl
beta
phenyl
active ingredient
Prior art date
Application number
PCT/EP1993/001743
Other languages
French (fr)
Other versions
WO1994001435A1 (en
Filing date
Publication date
Priority claimed from ITMI921659A external-priority patent/IT1255323B/en
Application filed filed Critical
Priority to SK18-95A priority Critical patent/SK1895A3/en
Priority to KR1019950700071A priority patent/KR100258336B1/en
Priority to AU45645/93A priority patent/AU4564593A/en
Priority to EP93915808A priority patent/EP0650486A1/en
Priority to JP6502940A priority patent/JPH07508739A/en
Publication of WO1994001435A1 publication Critical patent/WO1994001435A1/en
Publication of WO1994001435B1 publication Critical patent/WO1994001435B1/en
Priority to FI950029A priority patent/FI950029A/en
Priority to NO950053A priority patent/NO307518B1/en

Links

Abstract

Compounds of general formula (I), where Ar = phenyl or beta-naphtyl, R1 = one or more substituents of the phenyl or beta-naphtyl nucleus, preferably in para position, and selected out of the group consisting of H, CH3, C(CH3)3, CH2-CH-(CH3)2, O-CH3, C1, F, Br, CF3, NH2, S-CH3, SO-CH3, CN, NO2; R2 = H, CH3, C2H5, CH(CH3)2, CH2OH, C6H5; R3 = (a); where R4 = H, CH3, C2H5, CH(CH3)2, CH2-C6H5; R5 = H, CH3; X = none O, S, NH, NCH3; Y = O, NH, both in the racemic form and in the isomeric enantiomeric forms, which produce a nootropic effect, i.e. memory enhancement and learning facilitation, as well as an analgesic effect.

Claims

AMENDED CLAIMS
[received by the International Bureau on 28 February 1994 (28.02.94);
original claims 1, 5, 6-10 amended; remaining claims unchanged (4 pages)]
1) Compounds of general formula:
Figure imgf000003_0002
where Ar = phenyl or beta-naphtyl,
R1 = one or more substituents of the phenyl or beta-naphtyl nucleus, preferably in para position, and selected out of the group consisting of H, CH3. CH2-CH-(CH3)2, O-CHo, CI,
F, Br, CF3, NH2, S-CH3, CN, NO2
R2 = H, CH3, C2H5, CH(CH3)2,
Figure imgf000003_0001
where R4 = H, CH3, C2H5,
R5 = H, CH3
X = O, S, NH, NCH3
Y = O, NH,
both in the racemic form and in the isomeric enantiomeric forms.
2. Compounds according to claim 1, wherein R3 is 3-α-tropanil.
3. Procedure for the preparation of the compounds according to claim 1 consisting in the conversion of the corresponding carboxylic acid
Figure imgf000004_0003
into the chloride by reaction with SOCl2, followed by the reaction of the acyl chloride with compound HYR3 carried out in the presence of basic substances.
4. The procedure according to claim 3. wherein the carboxylic acid of general formula (II) is obtained from α-broπto alkanoic acid of general formula
Figure imgf000004_0001
by reaction, in the presence of basic substances, with a phenol or thiophenol of general formula
Figure imgf000004_0002
where X = O or S.
5. Analgesic and nootropic pharmaceutical compositions containing as active ingredient a compound of general formula:
Figure imgf000005_0001
where Ar = phenyl or beta-naphtyl,
R1 = one or more substituents of the phenyl or beta-naphtyl nucleus, preferably in para position, and selected out of the group consisting of H, CH3, CH2-CH-(CH3)2, O-CH3, CI,
F, Br, CF3, NH2, S-CH3, CN, N02
R2 = H, CH3, C2H5, CH(CH3)2,
Figure imgf000005_0002
where R4 = H, CH3, C2H5, R5 = H, CH3
X = none O, S, NH, NCH3
Y = O, NH,
both in the racemic form and in the isomeric enantiomeric forms.
6. Procedure for the preparation of the compounds according to claim 5. wherein X is absent and R5=H, characterized in that the intermediate compound of general formula
Figure imgf000005_0003
is obtained by esterification of the corresponding acid
Figure imgf000006_0004
with menthol, by alkylation of the menthol ester with alkyl iodide R2I, and finally by hydrolizing the alkylated menthol ester.
7 . The pharmaceutical compositions according to claim 5, containing suitable excipients for administration by the oral, intramuscular, subcutaneous, intravenous ways or as suppositories.
8. The composition according to claim 5, wherein the active ingredient is the following compound
Figure imgf000006_0002
9. The composition according to claim 5, wherein the active ingredient is the following compound
Figure imgf000006_0003
10. The pharmaceutical compositions according to claim 5, wherein the active ingredient is the following compound
Figure imgf000006_0001
PCT/EP1993/001743 1992-07-08 1993-07-06 New analgesic and nootropic drugs WO1994001435A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SK18-95A SK1895A3 (en) 1992-07-08 1993-07-06 Analgetic and nootropic drugs
KR1019950700071A KR100258336B1 (en) 1992-07-08 1993-07-06 New analgesic and nootropic drugs
AU45645/93A AU4564593A (en) 1992-07-08 1993-07-06 New analgesic and nootropic drugs
EP93915808A EP0650486A1 (en) 1992-07-08 1993-07-06 New analgesic and nootropic drugs
JP6502940A JPH07508739A (en) 1992-07-08 1993-07-06 Novel analgesic and nootropic agents
FI950029A FI950029A (en) 1992-07-08 1995-01-03 New analgesic and nootropic drugs
NO950053A NO307518B1 (en) 1992-07-08 1995-01-06 Therapeutically active compound for the treatment of cognitive deficits and pain

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI92A001659 1992-07-08
ITMI921659A IT1255323B (en) 1992-07-08 1992-07-08 COMPOUNDS WITH ANALGESIC AND NOOTROP ACTIVITY

Publications (2)

Publication Number Publication Date
WO1994001435A1 WO1994001435A1 (en) 1994-01-20
WO1994001435B1 true WO1994001435B1 (en) 1994-03-31

Family

ID=11363636

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1993/001743 WO1994001435A1 (en) 1992-07-08 1993-07-06 New analgesic and nootropic drugs

Country Status (14)

Country Link
US (1) US5583142A (en)
EP (1) EP0650486A1 (en)
JP (1) JPH07508739A (en)
KR (1) KR100258336B1 (en)
AU (1) AU4564593A (en)
CA (1) CA2139739A1 (en)
CZ (1) CZ2295A3 (en)
FI (1) FI950029A (en)
HU (1) HUT73481A (en)
IT (1) IT1255323B (en)
NO (1) NO307518B1 (en)
RU (1) RU95105457A (en)
SK (1) SK1895A3 (en)
WO (1) WO1994001435A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5794887A (en) 1995-11-17 1998-08-18 Komerath; Narayanan M. Stagnation point vortex controller
EP2206712A1 (en) * 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
RU2744571C1 (en) * 2020-04-10 2021-03-11 Общество с ограниченной ответственностью "ВладМиВа"(ООО "ВладМиВа") Dipharmacophoric compounds of nootropic-analgesic action and method for their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1289429A (en) * 1960-03-10 1962-04-06 Lepetit Spa Process for the preparation of the new esters of tropine
DE1670142A1 (en) * 1966-09-02 1970-07-16 Boehringer Sohn Ingelheim Process for the preparation of atropine, scopolamine and their N-substituted derivatives
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

Similar Documents

Publication Publication Date Title
RU92016217A (en) DOUBLE INHIBITORS NO SYNTHASE AND CYCLOOXYGENASE, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
FR2658818B1 (en) NOVEL DERIVATIVES WITH NAPHTHALENIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR920012040A (en) Novel Dihydro-Isquinoline Derivatives
IE841815L (en) Analgesic composition
KR860006464A (en) 6-thioxanthine derivative
KR940006580A (en) Substituted cyclohexane derivatives for treating diseases
EP0154234A3 (en) Substituted tyrosil alanine dipeptide amides
DK173553B1 (en) Amino acid derivatives, anticonvulsant preparation containing amino acid derivatives, and use of amino acid derivatives for promotion
RU96123227A (en) AMIDIC DERIVATIVES AND THEIR THERAPEUTIC USE
KR890013028A (en) Cephalosporin derivatives and their preparation
EA199800155A1 (en) NEW CONNECTION
WO1994001435B1 (en) New analgesic and nootropic drugs
KR900001675A (en) Compounds with bronchodilating action
KR910004193A (en) 5-Methyl-isoxazole-4-carboxylic acid anilide and 2-hydroxyethylidene-cyanoacetic acid anilide for treating ocular diseases
RU96101800A (en) AMIDA DERIVATIVES OF PHENYLCYCLOGAXYLICARBONIC ACID, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERES AND THEIR SALT, PHARMACEUTICAL COMPOSITION WITH ANTI-ARTERIOCLEROTIC AND ANTI-RETENCY
EP0135189A3 (en) Pharmaceutically useful malonamides
ES8506731A1 (en) Cephalosporin derivatives.
ATE212637T1 (en) ANTIBIOTICALLY EFFECTIVE CEPHALOSPORINS AND METHOD FOR THE PRODUCTION THEREOF
PT78071A (en) PROCESS FOR THE PREPARATION OF NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING MERCAPTOACEPTIC AND 3-MERCAPTOPROPIONIC ACID AMIDES DERIVATIVES
PH21612A (en) Trienamide compounds, their composition and method of using said compound
RU95107147A (en) Cyclohexanecarboxylic acid derivatives, mixture of isomers thereof or individual isomers and physiologically tolerable salts, and pharmaceutical composition having activity which inhibits enzymic glucose-phosphotase complex of liver
KR950702557A (en) New painkillers and nootropic drugs
KR910006292A (en) N-azabicyclo [3.3.0] octane amides of aromatic acids
JPS54125663A (en) Carcinostatic agent and novel compound having carcinostatic activity
JPS6440474A (en) Novel 2-substituted aminothiazole derivative